Oral Complications of Systemic Therapies: A Narrative Review of Interdisciplinary Prevention and Management
Saudi Journal of Medicine and Public Health · 31.12.2024 · 1 (2) · 2417-2429
DOI: 10.64483/202412676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Journal of Medicine and Public Health, online erschienen am 31.12.2024. Verfasst von Ghada Rashed Alotay und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Systemic cancer therapies, including chemotherapy, targeted agents, and immunotherapies, frequently induce oral complications that significantly impair patients' quality of life, nutritional status, and treatment adherence. These complications range from oral mucositis and xerostomia to immune-related oral adverse events, requiring coordinated interdisciplinary management.
Aim
This narrative review synthesizes current evidence on the prevention, assessment, and management of oral complications associated with systemic cancer therapies, with emphasis on interdisciplinary collaboration among oncology nurses, dentists, pharmacists, and laboratory professionals.
Methods
A comprehensive literature search was conducted across PubMed, Scopus, and Web of Science for peer-reviewed articles published between 2010 and 2024, focusing on oral complications, assessment tools, preventive strategies, and interprofessional interventions.
Results
Evidence demonstrates that professional oral health care and patient education programs significantly reduce oral mucositis incidence and severity. Dental pre-treatment optimization, particularly allowing ≥2 weeks healing time for extractions, reduces osteoradionecrosis risk. Immune checkpoint inhibitors are associated with distinct oral toxicities, including xerostomia (5% prevalence), mucositis (3%), and dysgeusia (3%). Laboratory biomarkers, including single-nucleotide polymorphisms in XRCC1 and inflammatory cytokines, show promise for predicting mucositis risk. Pharmacist-led medication management and nursing assessment tools are essential for early detection and intervention.
Conclusion
Effective management of oral complications requires integrated interdisciplinary approaches, standardized assessment protocols, and personalized preventive strategies. Future research should focus on validating predictive biomarkers and optimizing interprofessional care models.
Zitieren
APA
Alotay, G. R., Hummadi, M. S., Hamdi, M. Y. A., Al-Anazi, F. M., Manjahi, F. M. M., Alsahli, O. A., Abdulaal, K. A., Alhaysony, M. F. M., & Alalawi, T. A. M. (2024). Oral Complications of Systemic Therapies: A Narrative Review of Interdisciplinary Prevention and Management. Saudi Journal of Medicine and Public Health, 1(2), 2417-2429. https://doi.org/10.64483/202412676
Vancouver
Alotay GR, Hummadi MS, Hamdi MYA, Al-Anazi FM, Manjahi FMM, Alsahli OA, et al. Oral Complications of Systemic Therapies: A Narrative Review of Interdisciplinary Prevention and Management. Saudi Journal of Medicine and Public Health. 2024;1(2):2417-2429. doi:10.64483/202412676
BibTeX
@article{Alotay2024,
author = {Alotay, Ghada Rashed and Hummadi, Mohammed Saleh and Hamdi, Mousa Yahya Ahmad and Al-Anazi, Fatimah Mufadhi and Manjahi, Fatimah Mahboob Mohammad and Alsahli, Ohoud Abdulkarim and Abdulaal, Khulud Abdulaziz and Alhaysony, Mohammed Farhan Mohya and Alalawi, Turki Abdulaziz Mishaal},
title = {Oral Complications of Systemic Therapies: A Narrative Review of Interdisciplinary Prevention and Management},
journal = {Saudi Journal of Medicine and Public Health},
year = {2024},
volume = {1},
number = {2},
pages = {2417--2429},
doi = {10.64483/202412676}
}
EUVIMED